Published in Curr Opin Clin Nutr Metab Care on April 03, 2017
Towards developing standard operating procedures for pre-clinical testing in the mdx mouse model of Duchenne muscular dystrophy. Neurobiol Dis (2008) 2.20
Hsp72 preserves muscle function and slows progression of severe muscular dystrophy. Nature (2012) 2.04
Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness. Biogerontology (2008) 1.67
Adipose triacylglycerol lipase deletion alters whole body energy metabolism and impairs exercise performance in mice. Am J Physiol Endocrinol Metab (2009) 1.62
Improved contractile function of the mdx dystrophic mouse diaphragm muscle after insulin-like growth factor-I administration. Am J Pathol (2002) 1.48
Impaired skeletal muscle development and function in male, but not female, genomic androgen receptor knockout mice. FASEB J (2008) 1.46
The orphan nuclear receptor, NOR-1, a target of beta-adrenergic signaling, regulates gene expression that controls oxidative metabolism in skeletal muscle. Endocrinology (2008) 1.38
Whole body deletion of AMP-activated protein kinase {beta}2 reduces muscle AMPK activity and exercise capacity. J Biol Chem (2010) 1.30
Beta 2-agonist administration reverses muscle wasting and improves muscle function in aged rats. J Physiol (2003) 1.25
AMPK-independent pathways regulate skeletal muscle fatty acid oxidation. J Physiol (2008) 1.23
The orphan nuclear receptor, NOR-1, is a target of beta-adrenergic signaling in skeletal muscle. Endocrinology (2006) 1.21
Evaluating an internet weight loss program for diabetes prevention. Health Promot Int (2005) 1.21
Deletion of skeletal muscle SOCS3 prevents insulin resistance in obesity. Diabetes (2012) 1.20
Antibody-directed myostatin inhibition in 21-mo-old mice reveals novel roles for myostatin signaling in skeletal muscle structure and function. FASEB J (2010) 1.19
Systemic administration of beta2-adrenoceptor agonists, formoterol and salmeterol, elicit skeletal muscle hypertrophy in rats at micromolar doses. Br J Pharmacol (2006) 1.17
Low dose formoterol administration improves muscle function in dystrophic mdx mice without increasing fatigue. Neuromuscul Disord (2006) 1.16
Skeletal muscle glucose uptake during contraction is regulated by nitric oxide and ROS independently of AMPK. Am J Physiol Endocrinol Metab (2009) 1.16
Elevated expression of activins promotes muscle wasting and cachexia. FASEB J (2013) 1.13
Cellular mechanisms underlying temporal changes in skeletal muscle protein synthesis and breakdown during chronic {beta}-adrenoceptor stimulation in mice. J Physiol (2010) 1.11
Interleukin-15 administration improves diaphragm muscle pathology and function in dystrophic mdx mice. Am J Pathol (2005) 1.10
Optimizing plasmid-based gene transfer for investigating skeletal muscle structure and function. Mol Ther (2005) 1.10
Activated calcineurin ameliorates contraction-induced injury to skeletal muscles of mdx dystrophic mice. J Physiol (2006) 1.08
Antibody-directed myostatin inhibition enhances muscle mass and function in tumor-bearing mice. Am J Physiol Regul Integr Comp Physiol (2011) 1.08
Continuous testosterone administration prevents skeletal muscle atrophy and enhances resistance to fatigue in orchidectomized male mice. Am J Physiol Endocrinol Metab (2006) 1.08
Importance of functional and metabolic impairments in the characterization of the C-26 murine model of cancer cachexia. Dis Model Mech (2012) 1.08
Beta 2-agonist fenoterol has greater effects on contractile function of rat skeletal muscles than clenbuterol. Am J Physiol Regul Integr Comp Physiol (2002) 1.06
Notexin causes greater myotoxic damage and slower functional repair in mouse skeletal muscles than bupivacaine. Muscle Nerve (2006) 1.04
The calcineurin signal transduction pathway is essential for successful muscle regeneration in mdx dystrophic mice. Acta Neuropathol (2004) 1.03
Making fast-twitch dystrophic muscles bigger protects them from contraction injury and attenuates the dystrophic pathology. Am J Pathol (2009) 1.03
Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice. Am J Physiol Endocrinol Metab (2006) 1.02
Length-tension relationships are altered in regenerating muscles of the rat after bupivacaine injection. J Appl Physiol (1985) (2005) 0.98
Modulation of insulin-like growth factor (IGF)-I and IGF-binding protein interactions enhances skeletal muscle regeneration and ameliorates the dystrophic pathology in mdx mice. Am J Pathol (2007) 0.98
Administration of insulin-like growth factor-I improves fatigue resistance of skeletal muscles from dystrophic mdx mice. Muscle Nerve (2004) 0.97
Cytoskeletal tropomyosin Tm5NM1 is required for normal excitation-contraction coupling in skeletal muscle. Mol Biol Cell (2008) 0.96
Muscle-specific overexpression of IGF-I improves E-C coupling in skeletal muscle fibers from dystrophic mdx mice. Am J Physiol Cell Physiol (2007) 0.95
Update on emerging drugs for cancer cachexia. Expert Opin Emerg Drugs (2009) 0.94
Antibody-directed myostatin inhibition improves diaphragm pathology in young but not adult dystrophic mdx mice. Am J Pathol (2010) 0.94
Expression profiling of skeletal muscle following acute and chronic beta2-adrenergic stimulation: implications for hypertrophy, metabolism and circadian rhythm. BMC Genomics (2009) 0.94
Beta2-agonist administration increases sarcoplasmic reticulum Ca2+-ATPase activity in aged rat skeletal muscle. Am J Physiol Endocrinol Metab (2004) 0.93
Chronic beta2-adrenoceptor stimulation impairs cardiac relaxation via reduced SR Ca2+-ATPase protein and activity. Am J Physiol Heart Circ Physiol (2008) 0.92
Beta2-adrenoceptor agonist fenoterol enhances functional repair of regenerating rat skeletal muscle after injury. J Appl Physiol (1985) (2003) 0.91
Resistance exercise increases NF-κB activity in human skeletal muscle. Am J Physiol Regul Integr Comp Physiol (2011) 0.91
The potential and the pitfalls of beta-adrenoceptor agonists for the management of skeletal muscle wasting. Pharmacol Ther (2008) 0.90
Separation of fast from slow anabolism by site-specific PEGylation of insulin-like growth factor I (IGF-I). J Biol Chem (2011) 0.90
Plasmid-based gene transfer in mouse skeletal muscle by electroporation. Methods Mol Biol (2008) 0.89
Heritable pathologic cardiac hypertrophy in adulthood is preceded by neonatal cardiac growth restriction. Am J Physiol Regul Integr Comp Physiol (2009) 0.89
Chronic formoterol administration reduces cardiac mitochondrial protein synthesis and oxidative capacity in mice. Int J Cardiol (2010) 0.89
Excitation-contraction coupling and sarcoplasmic reticulum function in mechanically skinned fibres from fast skeletal muscles of aged mice. J Physiol (2002) 0.87
Differential calcineurin signalling activity and regeneration efficacy in diaphragm and limb muscles of dystrophic mdx mice. Neuromuscul Disord (2006) 0.87
Insulin-like growth factor-I analogue protects muscles of dystrophic mdx mice from contraction-mediated damage. Exp Physiol (2008) 0.87
Hydrogen peroxide increases depolarization-induced contraction of mechanically skinned slow twitch fibres from rat skeletal muscles. J Physiol (2002) 0.86
Acute antibody-directed myostatin inhibition attenuates disuse muscle atrophy and weakness in mice. J Appl Physiol (1985) (2011) 0.86
Therapeutic clenbuterol treatment does not alter Ca2+ sensitivity of permeabilized fast muscle fibres from exercise trained or untrained horses. J Muscle Res Cell Motil (2003) 0.86
Depolarization-induced contraction and SR function in mechanically skinned muscle fibers from dystrophic mdx mice. Am J Physiol Cell Physiol (2003) 0.86
Stimulation of calcineurin Aalpha activity attenuates muscle pathophysiology in mdx dystrophic mice. Am J Physiol Regul Integr Comp Physiol (2008) 0.85
Changes in contractile activation characteristics of rat fast and slow skeletal muscle fibres during regeneration. J Physiol (2004) 0.85
Chronic beta-agonist administration affects cardiac function of adult but not old rats, independent of beta-adrenoceptor density. Am J Physiol Heart Circ Physiol (2005) 0.84
Calcineurin-A alpha activation enhances the structure and function of regenerating muscles after myotoxic injury. Am J Physiol Regul Integr Comp Physiol (2007) 0.84
beta-Adrenoceptor signaling in regenerating skeletal muscle after beta-agonist administration. Am J Physiol Endocrinol Metab (2007) 0.84
Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy. Exp Physiol (2014) 0.84
Early functional muscle regeneration after myotoxic injury in mice is unaffected by nNOS absence. Am J Physiol Regul Integr Comp Physiol (2011) 0.83
Inhibition of the renin-angiotensin system improves physiological outcomes in mice with mild or severe cancer cachexia. Int J Cancer (2013) 0.83
Attenuation of age-related muscle wasting and weakness in rats after formoterol treatment: therapeutic implications for sarcopenia. J Gerontol A Biol Sci Med Sci (2007) 0.83
Ageing prolongs inflammatory marker expression in regenerating rat skeletal muscles after injury. J Inflamm (Lond) (2011) 0.82
Leucine as a treatment for muscle wasting: a critical review. Clin Nutr (2014) 0.81
The effects of osteoarthritis and age on skeletal muscle strength, Na+-K+-ATPase content, gene and isoform expression. J Appl Physiol (1985) (2013) 0.81
Repeated sprints alter signaling related to mitochondrial biogenesis in humans. Med Sci Sports Exerc (2012) 0.81
Disruption of muscle renin-angiotensin system in AT1a-/- mice enhances muscle function despite reducing muscle mass but compromises repair after injury. Am J Physiol Regul Integr Comp Physiol (2012) 0.81
Editorial update on emerging drugs for cancer cachexia. Expert Opin Emerg Drugs (2012) 0.80
Novel role for ß-adrenergic signalling in skeletal muscle growth, development and regeneration. Clin Exp Pharmacol Physiol (2009) 0.80
Intramuscular beta2-agonist administration enhances early regeneration and functional repair in rat skeletal muscle after myotoxic injury. J Appl Physiol (1985) (2008) 0.80
Association between skeletal muscle inflammatory markers and walking pattern in people with knee osteoarthritis. Arthritis Care Res (Hoboken) (2011) 0.79
Early inflammatory and myogenic responses to resistance exercise in the elderly. Muscle Nerve (2012) 0.79
Identification of FHL1 as a therapeutic target for Duchenne muscular dystrophy. Hum Mol Genet (2013) 0.79
Therapeutic potential of PEGylated insulin-like growth factor I for skeletal muscle disease evaluated in two murine models of muscular dystrophy. Growth Horm IGF Res (2012) 0.79
Hyperbaric oxygen increases the contractile function of regenerating rat slow muscles. Med Sci Sports Exerc (2002) 0.79
Amino acid sensing and activation of mechanistic target of rapamycin complex 1: implications for skeletal muscle. Curr Opin Clin Nutr Metab Care (2016) 0.79
On the relationship between discrete and repetitive lifting performance in military tasks. J Strength Cond Res (2014) 0.78
Intramuscular administration of PEGylated IGF-I improves skeletal muscle regeneration after myotoxic injury. Growth Horm IGF Res (2013) 0.78
Downstream mechanisms of nitric oxide-mediated skeletal muscle glucose uptake during contraction. Am J Physiol Regul Integr Comp Physiol (2010) 0.78
Disease-Induced Skeletal Muscle Atrophy and Fatigue. Med Sci Sports Exerc (2016) 0.77
Unchanged [3H]ouabain binding site content but reduced Na+-K+ pump α2-protein abundance in skeletal muscle in older adults. J Appl Physiol (1985) (2012) 0.77
Emerging drugs for treating skeletal muscle injury and promoting muscle repair. Expert Opin Emerg Drugs (2011) 0.77
Effects of leukemia inhibitory factor on rat skeletal muscles are modulated by clenbuterol. Muscle Nerve (2002) 0.77
Physiological characterization of a mouse model of cachexia in colorectal liver metastases. Am J Physiol Regul Integr Comp Physiol (2013) 0.77
Arginine protects muscle cells from wasting in vitro in an mTORC1-dependent and NO-independent manner. Amino Acids (2014) 0.76
A comparison of the effects of fatigue on subjective and objective assessment of situation awareness in cycling. J Sports Sci Med (2006) 0.75
Parvalbumin gene transfer impairs skeletal muscle contractility in old mice. Hum Gene Ther (2012) 0.75
The relationship between maximal lifting capacity and maximum acceptable lift in strength-based soldiering tasks. J Strength Cond Res (2012) 0.75
Endurance training adaptations modulate the redox-force relationship of rat isolated slow-twitch skeletal muscles. Clin Exp Pharmacol Physiol (2003) 0.75
The role of beta-adrenoceptor signaling in skeletal muscle: therapeutic implications for muscle wasting disorders. Curr Opin Clin Nutr Metab Care (2009) 0.75
Skeletal effects of the alteration of masseter muscle function. Aust Orthod J (2015) 0.75
Maximal and sub-maximal functional lifting performance at different platform heights. Ergonomics (2014) 0.75